000 01602 a2200457 4500
005 20250513224033.0
264 0 _c20001206
008 200012s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.2000.tb06873.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFiglewicz, D A
245 0 0 _aCulture models of neurodegenerative disease.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_c2000
300 _a106-18 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Count
650 0 4 _aCell Size
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aGrowth Substances
_xpharmacology
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMotor Neurons
_xcytology
650 0 4 _aNeurodegenerative Diseases
_xchemically induced
650 0 4 _aOxidative Stress
_xphysiology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSpinal Cord
_xcytology
650 0 4 _aSuperoxide Dismutase
_xgenetics
650 0 4 _aSuperoxide Dismutase-1
650 0 4 _aTransfection
700 1 _aDong, L
700 1 _aMlodzienski, M
700 1 _aTurcotte, J C
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 919
_gp. 106-18
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.2000.tb06873.x
_zAvailable from publisher's website
999 _c11024759
_d11024759